BA
Balyasny Asset Management L.P. disclosed a 7.4% stake in IRD
Balyasny Asset Management L.P. reported owning 7.4% of Opus Genetics, Inc. (IRD) (6,120,982 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.